Vascular Medicine

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joffe, H. V
Right arrow Articles by Goldhaber, S. Z
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joffe, H. V
Right arrow Articles by Goldhaber, S. Z
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Vascular Medicine, Vol. 7, No. 2, 93-102 (2002)
DOI: 10.1191/1358863x02vm426ra
© 2002 SAGE Publications

Laboratory thrombophilias and venous thromboembolism

Hylton V Joffe

Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Samuel Z Goldhaber

Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, sgoldhaber{at}partners.org

Inherited abnormalities of coagulation are increasingly recognized in patients with venous thromboembolism. Common causes of hypercoagulability, also known as thrombophilia, include factor V Leiden, the prothrombin gene mutation, hyperhomocysteinemia, and antiphospholipid antibodies. Thrombophilia should be suspected in patients who develop idiopathic venous thromboembolism at a young age, recurrent thrombosis, thromboses at unusual sites, recurrent unexplained pregnancy loss, or if there is a family history of thrombotic disorders. The most cost-effective approach is to initially screen for factor V Leiden, the prothrombin gene mutation, hyperhomocysteinemia, and antiphospholipid antibodies because these are the most common defects causing thrombophilia. Long-term anticoagulation is controversial but should be considered if unprovoked venous thromboembolism recurs.

Key Words: genetic • hypercoagulability • inherited • thrombophilia • venous thromboembolism


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
S. Z. Goldhaber and C. G. Elliott
Acute Pulmonary Embolism: Part I: Epidemiology, Pathophysiology, and Diagnosis
Circulation, December 2, 2003; 108(22): 2726 - 2729.
[Full Text] [PDF]

Home page
 HeartHome page
R. D Rakhit
Learning on the Web. Case 2: patent foramen ovale (PFO) and paradoxical embolism.
Heart, November 1, 2003; 89(11): 1362 - 1362.
[Full Text]